E-mail Print PDF

To provide substantial evidence to establish the efficacy of a treatment for pain, the FDA and European agencies encourage evaluation of a test drug in multiple models and pain populations.

Andronovo has conducted a broad range of successful pain-focused clinical trials using different pain models at all stages of analgesic development - from proof-of-concept through Phase IV. Our key areas of clinical expertise in pain include chronic neuropathic pain including postherpetic neuralgia and painful diabetic neuropathy; chronic lower back pain; cancer pain; osteoarthritis and rheumatoid arthritis; acute post-surgical pain, sprains and strains, and acute low back pain; and migraine.

Our core group of pain specialists realizes that pain evaluation has not evolved to a standardized approach, and expertise in various models and key pain assessments is required. To be truly successful in helping our customers develop drugs and devices for the treatment of pain, we follow the methodology of our Trusted Process and work closely with them, drawing on our extensive database of academic and private practice physician investigators, to develop the best approach, customized to achieve their particular objectives.

For more information on Andronovo’s therapeutic expertise in Pain, click here.

Contact Us

For a quick business enquiry, feel free to contact us.